Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).
about
Adjuvant radiotherapy following radical prostatectomy for prostate cancerImportance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trialMagnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer.Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.Significance and management of positive surgical margins at the time of radical prostatectomyVariation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.Influence of pathologist experience on positive surgical margins following radical prostatectomy.Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy.Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy.Pathology Imagebase-a reference image database for standardization of pathology.Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.Improving postoperative radiotherapy following radical prostatectomy.Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
P2860
Q24234347-2C1B747E-4ABE-4DDF-993E-0EB09B601530Q36227221-C474B00C-9B6E-4F5A-9B54-2FD9B3359F09Q37819234-46DEB63E-E85C-41B5-A216-E6B9C706B302Q37832487-67FFC739-2B67-481E-AE3E-F4189FFAFEC0Q38125826-46F9A1ED-4DB4-415B-B7A6-740EC1398CA5Q38266018-779C7FEB-566F-4B6A-996F-B341B629D9E4Q38384899-37AF5F07-545D-4D8A-B6C7-88E17BC258BDQ39182622-C100481A-4468-4415-B991-6B0A5E60839AQ39695483-D8AF32DD-4841-406E-ADD2-970BEFCA75ADQ39823876-15A84C12-9B83-41F9-A95A-30329B3F6282Q40116896-B8DC77E8-72D2-42F2-9966-D643841EA7F3Q40460159-047B8FE7-136B-40E7-A042-C7BA12F363B0Q42623443-C844C969-DF3B-4E06-B031-76730EEE9FDDQ47978964-1A98713E-3C8F-4EAE-9DEA-9A5311E21629Q48524997-371F53A7-31A6-4A4D-8DDD-EC4C1DCA85CF
P2860
Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Impact of pathology review of ...... specimens (EORTC trial 22911).
@ast
Impact of pathology review of ...... specimens (EORTC trial 22911).
@en
type
label
Impact of pathology review of ...... specimens (EORTC trial 22911).
@ast
Impact of pathology review of ...... specimens (EORTC trial 22911).
@en
prefLabel
Impact of pathology review of ...... specimens (EORTC trial 22911).
@ast
Impact of pathology review of ...... specimens (EORTC trial 22911).
@en
P2093
P1433
P1476
Impact of pathology review of ...... specimens (EORTC trial 22911).
@en
P2093
European Organisation for Rese ...... d Genito-Urinary Cancer Groups
Fritz H Schröder
Hein Van Poppel
Jean-François Bosset
Karl H Kurth
Kris Vekemans
Laurence Collette
Luigi DaPozzo
Michel Bolla
Paul Van Cangh
P2888
P304
P356
10.1007/S00428-006-0254-X
P577
2006-08-29T00:00:00Z